Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndrome (MDS)

Explore clinical trials studying Myelodysplastic Syndrome (MDS). Study availability and eligibility vary by location and protocol.

57 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndrome (MDS) trial results

Completed

Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM

NCT01816230

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +18 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Loyola University, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Steven and Alexandra Cohen Children's Medical Center New York, United States
View all 15 locations
View Trial Details
Completed

Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

NCT02212561

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +17 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

NCT01929408

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • University of Maryland Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

NCT02920541

Conditions
Acute Myeloid Leukaemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • The Alfred Hospital Melbourne, Australia
  • Royal Melbourne Hospital Parkville, Australia
  • Institut Paoli Calmettes Marseille, France
  • Hôpital Saint Louis Paris, France
View Trial Details
Completed

Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome

NCT01599325

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Peking University People's Hospital Beijing, China
  • The 301 Hospital- Chinese PLA General Hospital Beijing, China
  • The Third Hospital of Peking University Beijing, China
  • West China Hospital of Sichuan University Chengdu, China
View Trial Details
Completed

Darbepoetin Alfa MDS Companion Protocol

NCT02175277

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Research Site Charleroi, Belgium
  • Research Site Leuven, Belgium
  • Research Site Liège, Belgium
  • Research Site Sint-Niklaas, Belgium
View Trial Details

Related conditions